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Anioniiation of an antigen promotes glomerular binding and immune
complex formation. Bovine serum albumin (BSA, p1 4.9) was maley-
lated to yield highly anionic MBSA (p1 3.0). Maleylation of BSA lead to
an expansion of molecular size of native BSA from an effective
molecular radius (EMR) of 37 A to 57 A for MBSA as assessed by gel
ifitration chromatography. MBSA, but not BSA, bound to the periph-
eral capillary wall (PCW) and mesangium in vitro in frozen sections,
and in vivo following i.v. injection (0.006 mg/g body wt), examined by
immunofluorescence. When similarly injected rats or controls were
given antibodies to either MBSA or BSA following injection of antigen,
immune complexes were observed in glomeruli by immunofluorescence
and EM only in MBSA injected rats. Deposits occurred in the mesan-
gium and subendothelium in the PCW. In frozen sections, bound MBSA
could be partially removed from tissue sections by high ionic strength
buffer. Also, binding of MBSA was diminished by prior treatment of
sections with synthetic polyanions. Maleylated bovine gamma-globulin
and succinylated BSA showed identical binding patterns as described
for MBSA, indicating that binding was not unique to the modified BSA
molecule nor to the form of anionization. These results indicate that
charge interactions between circulating highly anionic macromolecules
and cationic domains within glomerular structures are responsible, in
part, for MBSA binding and subsequent localization of immune com-
plexes. Furthermore, it is inferred that the selective binding of MBSA
to glomeruli and formation of immune complexes occurred by a
mechanism not related to difference in size between MBSA and BSA.
These findings are different from conventionally understood charge
interactions in glomerular immune complex formation.
The glomerular basement membrane (GBM) is richly en-
dowed with polyanionic moieties that impart an electrostatic
barrier to circulating negatively charged macromolecules [1—3].
Synthetic and native polycationic molecules have an affinity to
glomerular polyanion [3—5]; thus, transfer into or through the
filtration barrier is facilitated by ionic interactions. Moreover,
glomerular localization of immune deposits is governed in part
by charge interactions between glomerular polyanion and cir-
culating immune reactants [6—8]. A net positive charge on the
immune reactant favors GBM localization of immune deposits
while a net negative charge leads to mesangial localization
[6—8]. Furthermore, neutralization of glomerular anionic sites
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leads to enhancement of glomerular immune complex localiza-
tion [9].
The GBM is also comprised, in part, of type V and type IV
collagen [10], which have been shown to be cationic with
isoelectric points (p1) in the range of 8.3 to 9.0 [11]. Recent
studies have shown that negatively-charged native proteins
such as IgG4 (p1 = 5.5 to 6.3), alpha-i acid glycoprotein (p1 =
2.7), amyloid P (p1 = 3.9 to 4.8), and alpha-i antitrypsin (p14.5)
localize in glomerular basement membranes in normal or dis-
eased kidneys, presumably by electrostatic interactions with
fixed positive charges on proteins, such as collagen [12].
Moreover, glomerular permeability to glycosylated albumin and
ferritin has been shown to be facilitated compared to the native,
less anionic, forms of these same molecules [13, 14]. Similarly
DNA, a highly charged polyanion, is capable of binding to
collagen and GBM in vitro [15].
The potential for certain anionic proteins to bind to the GBM,
a structure which also has an overall net negative charge [1—4],
suggests that interaction of macromolecules with the GBM may
be more complex than hitherto considered. For example, inter-
action between unique domains on proteins and molecular
complexes in the GBM may impart specificities that override
simple overall electrostatic attraction and repulsion. These
considerations led us to examine the relative capacities of
native bovine serum albumin (BSA) and highly negatively
charged, chemically modified BSA (maleylated BSA, MBSA) to
bind to the GBM and how this may relate to the local glomerular
formation of immune complexes.
Methods
Proteins
Bovine serum albumin (BSA, Cohn fraction V from Sigma
Chemical Co., St. Louis, Missouri, USA) was dialyzed exten-
sively against 0.02 M phosphate buffered saline, pH 7.3 (PBS)
prior to use. BSA was then modified with maleic anhydride to
make it highly negatively charged. One gram of BSA was added
and diluted into 100 ml PBS, pH 7.3, cooled on ice and then
placed on a magnetic stirrer. Two grams of maleic anhydride
crystals (Sigma Chemical Co.) were added to the solution and
the pH maintained at 7.0 for 20 minutes. The solution was then
extensively dialyzed against PBS, filtered into sterile vials, and
stored at 4°C until needed. In a separate study blood elimination
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of MBSA and BSA was examined. The proteins (BSA and
MBSA) were trace labeled with '25lodine (1251), using chioram-
ine-T derivatized polystyrene beads (iodo-beads, Pierce Chem-
ical Co., Rockford, Illinois, USA). Following iodination, free
1251 was removed from the solution by gel filtration through a
sephadex G75 column and by dialysis against PBS. Protein
precipitation with 30% trichloroacetic acid immediately prior to
injection into rats revealed that between 94 and 98% of total
counts were attributed to '251-incorporated protein.
To assess alterations in molecular size of BSA following
maleylation, the relative electrophoretic mobility (Rf) of both
BSA and MBSA were compared to standards in 0.1% sodium
dodecyl sulphate, 10% polyacrylamide gels [161. In addition,
globular size of MBSA and BSA was examined by gel filtration
utilizing a 1.5 cm X 90 cm column containing sephadex G-200
calibrated with ovalbumin, BSA, catalase, ferritin and blue
dextran. Maleylation of BSA (Mr 66,000) slightly increased the
average molecular weight of MBSA (Mr 71,000 daltons), as
determined by electrophoresis, an observation similar to that
previously reported by Tung and Knight [17]. However, the
globular size of MBSA was determined to be larger than BSA
based on gel filtration showing an effective molecular radius
(EMR) of 57 A compared to 35 A for BSA; an observation in
agreement with that of Habeeb [181 for similarly anionized
BSA. In addition, a small peak (approximately 10% of the total
protein chromatographed) was determined to have an EMR of
67 A. Intravenous injection of proportionate amounts of this
larger sized MBSA, exclusively, resulted in no or negligible
glomerular localization. Thus, nearly all glomerular localization
of MBSA could be attributed to localization of the smaller 57 A
MBSA since injection of proportionate amounts of this species
of MBSA resulted in strong mesangial and peripheral capillary
wall localization (Results).
Antibodies
New Zealand white rabbits were immunized by repeated
injections of each protein suspended in complete Freund's
adjuvant (H37Ra, Difco Laboratories, Detroit, Michigan, USA)
[19]. The rabbits were bled, sera assayed by immuno-diffusion
and the strongest antisera were pooled. Pooled serum was
fractionated by precipitation with 18% saturated sodium sulfate
and dialyzed against PBS, pH 7.3. Antibody concentration was
assayed by quantitative immunoprecipitin analysis [201. For
immune complex studies the immunoglobulin fractions (anti-
BSA and anti-MBSA) were matched prior to injection into rats
to give a specific antibody content of 2.1 mg/mI of antibody in a
solution containing approximately 16 mg/ml of total protein.
Anti-MBSA did not cross react with BSA nor did anti-BSA
cross react with MBSA in immunodiffusion gels. Protein con-
centration in all solutions used was determined by the method
of Lowry et al [211.
Determination of isoelectric points (p1)
The isoelectric points (p1) of native and modified protein and
immunoglobulin fractions was determined by analytical isoelec-
tric focusing on slab gels of 4.5% acrylamide and 0.7% bis-
acrylamide containing 2.5% Ampholine (pH range 3.5 to 10)
and/or by isoelectric precipitation by titration. The average p1
of BSA and MBSA were 4.9 and 3.0, respectively. Anti-BSA
and anti-MBSA fractions used for immune complex studies
were identical in their electrofocusing profiles.
In vitro binding studies
Binding of MBSA to rat kidney cortex was assessed by
indirect immunofluorescence according to the following proce-
dure. Rat kidneys were washed free of blood by perfusion with
PBS and the kidney cortex was trimmed and then frozen in
isopentane prechilled in liquid nitrogen. MBSA or BSA (1.0
mg/ml) in PBS was layered onto 8 jim frozen sections and
allowed to incubate for 15 minutes, washed with PBS, then
incubated with the appropriate rabbit primary antibody fol-
lowed by fluorescein-conjugated goat anti-rabbit IgG (Cappel
Laboratories, Westchester, Pennsylvania, USA). Controls con-
sisted of sections layered with PBS followed by antibody or
sections layered with MBSA or BSA followed by normal
nonimmune rabbit serum.
To examine ionic interactions between MBSA and glomeru-
lar structures, sections were washed after incubation with
MBSA with phosphate buffer containing increasing concentra-
tions of sodium chloride (0.15, 1.0 and 3.0 M). In addition,
sections were incubated with synthetic polyanions dextran
sulfate, heparin or pentosan polysulfate prior to layering with
anionized proteins to examine competitive binding of polyan-
ions with glomerular structures. To critically examine the effect
of negative charge on binding of anionic molecules to glomer-
ular structures, additional studies were performed in vitro using
a different molecule, bovine gamma globulin (BGG) for maley-
lation (same procedure as for BSA) and a different molecule for
anionization (succinylation) of BSA. The procedure for sue-
cinylation was similar to maleylation except maleic anhydride
was replaced by succinic anhydride in the reaction mixture.
These methods also produced highly anionic proteins like
MBSA: average p1's of MBGG = 3.2 compared to native BGG
p1 = 6.8. SBSA had an average p1 of 3.2. Identical procedures
were used, as described above, to examine binding of these
modified proteins to glomerular structures.
In vivo binding studies
To critically examine the binding potential of anionized
protein to glomerular structures in vivo, the following protocol
using MBSA and BSA was employed. Twenty-four male,
Sprague-Dawley rats were divided into two groups and lightly
anesthetized with ether. MBSA or BSA was injected intrave-
nously via a tail vein to deliver 0.006 mg/g body weight and the
rats were allowed to recover. An additional group of control
rats was treated as above but received diluent in place of the
respective albumin solution. The rats were reanesthetized with
sodium pentobarbital and at 30 minutes after the initial injec-
tion, a mid-abdominal incision was made, the left renal pedicle
ligated and the left kidney excised, and portions of the renal
cortex were then prepared for immunofluorescence localization
of MBSA and BSA. Immediately following removal of the left
kidney, the right kidney was fixed by perfusion with 1.25%
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4 and subse-
quently processed for light and electron microscopy by routine
laboratory techniques.
In an additional study, elimination of circulating MBSA (N =
4) and BSA (N = 4) was examined by following the disappear-
ance of '251-labeled proteins from the blood over a 30 minute
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period after injection. '251-labeled MBSA or BSA was injected
via the tail vein as outlined above. In each rat, blood samples
were collected immediately after a five-minute equilibration
period and at 15 and 30 minutes following injection of the label.
At termination of the study, kidney tissue was removed for
immunofluorescence microscopy. In additional rats, a sample
of plasma was obtained for gel filtration chromatography to
monitor alterations in size of circulating MBSA.
Immune complex studies with heterologous antibody
A total of 21 rats were divided into three groups and anes-
thetized with ether. The first group (N = 11) received MBSA at
a dose of 0.006 mglg body weight followed 30 minutes later with
1.5 ml of anti-MBSA to deliver a total of 3.1 mg anti-MBSA
antibody. Thirty minutes after administration of the anti-
MBSA, the rats were sacrificed and kidney tissue processed for
immunofluorescence, light and electron microscopy as outlined
above. The second group (N = 6) was treated in an identical
fashion as the first group except BSA and anti-BSA were given
in place of MBSA and anti-MBSA. As a control, a third group
(N = 4) was given PBS in place of MBSA solution followed by
anti-MBSA.
Glomerular localization of immune complexes was assessed
by indirect immunofluorescence of kidney sections for localiza-
tion of MBSA or BSA and rabbit IgG and by the ultrastructural
demonstration of dense deposits.
Results
Binding studies
Immunofluorescence evaluation of sections layered with all
anionized proteins (MBSA, MBGG, SBSA) revealed a promi-
nent localization in glomerular mesangium as well as in periph-
eral capillary loops (Figs. lA, 2A, B). In addition, Bowman's
capsule and tubular basement membranes stained for anionic
proteins (Figs. 1A, 2A, B). Sections incubated with the native
forms of these proteins showed only background staining (Fig.
lB). Control sections were negative. An ionic interaction be-
tween modified proteins and glomerular structures was sug-
gested by a decreased glomerular and tubular basement mem-
brane staining following washing with buffer containing high
concentrations of salt (>0.5 M; Fig. lC). Also binding of all
modified proteins could be substantially blocked by prior incu-
bation with synthetic polyanions, dextran sulfate, heparin and
pentosan polysulfate (Figs. 1D, 2C, D). Glomerular localization
of MBGG and SBSA (Figs. 2A, B) was identical to that
observed for MBSA. Like MBSA, binding of MBGG and SBSA
could be eluted from sections with high salt buffer or by prior
blocking with synthetic polyanions (Figs. 2C, D).
In vivo, localization of MBSA was observed within the
mesangium and in a linear pattern along peripheral capillary
loops of all glomeruli (Fig. 3A). Staining of MBSA in Bowman's
capsule and tubular basement membranes was also observed.
In addition, proximal tubules showed staining of MBSA in
protein absorption droplets (Fig. 3A). Intravenous administra-
tion of BSA did not result in localization of the protein in any
glomerular or tubular structures (Fig. 3B). Controls injected
with saline without MBSA or BSA were also negative.
Blood elimination of 1251-MBSA and '251-BSA revealed sim-
ilar patterns of disappearance. The injection of MBSA or BSA
at a dose of 0.006 mg/g body weight gives a calculated blood
concentration of 85.7 g/ml, based on the estimated blood
volume of 7.0% of the body weight of each rat. Blood concen-
trations of MBSA were measured to be 56.0 10.2 p.g/ml at 5
minutes, 49.8 8.9 sg/ml at 15 minutes, and 41.0 7.3 pg/ml
at 30 minutes. Blood concentrations of BSA were measured to
be 57.6 1.2 g/ml at 5 minutes, 53.8 1.6 sg/ml at 15
minutes, and 49.8 1.1 p,g/ml at 30 minutes. The measured
values of blood concentration of MBSA were somewhat less
than that observed for BSA; however, Wilcoxon rank analysis
revealed no significant difference between the two groups.
Immunofluorescence microscopy showed identical binding pat-
terns for '251-MBSA as described for unlabeled MBSA de-
scribed above. Like unlabeled BSA, '251-BSA did not stain
glomerular or tubular structures. lodination did not change the
globular size of MBSA nor BSA. However, a slight increase in
globular size of circulating MBSA from an EMR 57 A to 60 A
was detected by gel filtration chromatography.
Immune complex studies
Immunofluorescence evaluation of sections from rats given
MBSA followed by anti-MBSA revealed a localization of rabbit
IgG and MBSA within the glomerular mesangium (Figs. 4A, B).
A linear localization of rabbit IgG and MBSA was observed in
peripheral capillary loops; however, the intensity was not as
prominent as that observed in the mesangium (Figs. 4A, B).
Localization of rabbit IgG and BSA in rats given BSA followed
by anti-BSA were negative (Figs. 4C, D). Similarly, rats in-
jected with saline followed by anti-MBSA did not show local-
ization of MBSA or rabbit IgG in glomerular structures.
Electron microscopical evaluation of glomeruli from rats
injected with MBSA followed by anti-MBSA showed intact
glomerular endothelial, epithelial, and mesangial cells (Figs.
5A, B). Also, electron dense deposits were observed along
subendothelial aspects of the GBM and within the mesangial
matrix. Subendothelial deposits were heterogeneous in texture,
showing light amorphous material and/or multiple small densi-
ties (Figs. 5A, B). Mesangial deposits were present but had
minimal electron density and were difficult to assess. Ultra-
structural alterations or dense deposits were not observed
within glomerular structures in rats given native BSA followed
by anti-BSA (Fig. SC) or in controls given saline plus anti-
MBSA.
Discussion
This study shows that altering the charge of BSA or BGG to
make it highly anionic imparts on the molecule an affinity for
glomerular mesangium and peripheral capillary walls in vitro
and in vivo. Furthermore, by virtue of its binding affinity to
glomerular structures, MBSA enhances immune complex local-
ization when compared to native BSA in a model where
antibody is passively administered after the antigen. These
findings cannot be explained by conventionally understood
mechanisms of glomerular localization of proteins and immune
complexes by charge interactions. For example, a variety of
synthetic and native polycations are known to have an affinity
to glomerular polyanions through ionic interactions [1—5]. Gb-
merular permeability to macromolecules is influenced by charge
interactions between macromolecules (including immune reac-
tants) and glomerular polyanions. Such interactions have been
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Fig. 1. Frozen sections of kidney cortex layered with MBSA (A) or BSA (B) followed by indirect immunofluorescence. MBSA localizes in
glomerular capillary loops, the mesangium and Bowman's capsule as well as tubular basement membrane. Staining for native BSA was absent.
Washing sections incubated with MBSA with buffer containing 3.0 M NaCI (C) removes bound MBSA. Also, prior incubation of sections with
synthetic polyanions (Dextran sulfate) prior to layering MBSA (D) diminishes binding of MBSA.
shown to be determining factors in the localization of immune
complexes [6—8] in that a net positive charge of the immune
reactant favors GBM localization of immune deposits and a net
negative charge favors mesangial localization.
A variety of factors are known to influence glomerular
localization of macromolecules and immune complexes [22, 23].
These include molecular size, charge, prolonged and/or in-
creased blood level, physiologic factors including mesangial cell
function, hemodynamic forces and characteristics of the gb-
merular capillary wall itself. Mesangial accumulation of pro-
teins is directly related to blood concentration or prolonged
clearance [24, 25]. However, in this study, localization of
MBSA in gbomerular structures does not appear to be related to
blood levels or prolonged clearance of the molecule. MBSA
was removed from the circulation slightly, but not significantly,
faster than BSA; thus, blood levels were lower than BSA over
the time course of the study. Glomerular localization of MBSA
was markedly pronounced despite lower blood levels when
compared to native BSA, an observation opposite of that
expected if localization was proportionate to circulating levels.
Molecular size may, in part, be responsible for the disparity
in gbomerular localization since MBSA was determined to be
larger than BSA with respective molecular radii of 60 A and 35
A in the circulation. Yet, despite its larger size, gbomerular
filtration of MBSA was facilitated as documented by the obser-
vation of numerous proximal tubular protein absorption drop-
lets containing MBSA. Conversely, BSA, with a smaller mo-
lecular weight, was restricted by the glomerular capillary wall.
Localization of MBSA in protein absorption droplets may, in
part, be explained by a resistance of the modified protein to
enzymatic hydrolysis within tubules compared to BSA. How-
ever, facilitated filtration of the protein seems more likely since
localization of BSA was not observed in any segment of the
proximal tubule, even in experiments in which tissue was
examined within five minutes following injection (unpublished).
Similarly, it is not likely that these differences in molecular size
can account for the disparity in mesangial localization of MBSA
and BSA. Glomerular accumulation of native ferritin, which has
a larger molecular size (61 A) than MBSA (60 A), is negligible
even at doses much higher than those used in this study.
Mesangial accumulation of aggregated albumin, IgG or immune
complexes greater than 900,000 daltons will occur in a dose and
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Fig. 2. Frozen sections of kidney cortex layered with MBGG (A) or SBSA (B) followed by indirect immunofluorescence. Glomerular staining is
similar to that observed for MBSA. Preincubation with pentosan polysulfate (C) or heparin sulfate (D) blocks subsequent binding of MBGG (C)
or SBSA (D).
Fig. 3. Frozen sections of kidney cortex from rats injected with MBSA (A) or BSA (B). Immunofluorescence staining revealed MBSA localization
in glomerular capillary loops and mesangium. Absorption droplets containing MBSA are evident in adjacent proximal tubules. Staining for native
BSA was absent.
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Fig. 4. Glomeruli from rats injected with MBSA followed by anti-MBSA (A and B). Sections stained for MBSA (A) and rabbit IgG (B) show
glomerular capillary loop and mesangial localization. Glomeruli from rats injected with native BSA followed by anti-BSA showed only background
immunofluorescence for BSA (C) and rabbit IgG (D).
time dependent fashion, but smaller forms of these same
macromolecules localize poorly [23—25]. Also, the binding data
observed in vitro is independent of molecular size. This data,
together with the high affinity of MBSA to glomerular structures
in vivo suggests that mechanisms other than physical size of the
molecule are determining factors in glomerular localization.
Physiological factors such as mesangial cell function and
hemodynamic effects may also, in part, influence glomerular
localization of MBSA; however, a direct molecular interaction
between MBSA and glomerular structures seems more likely
since layering MBSA onto kidney sections in vitro yielded
strong staining of the same glomerular structures observed
following injection of MBSA in vivo, a finding that would also
be independent of physiological forces.
The nature of the binding of highly anionic proteins to
glomerular structures is not known. Binding of modified pro-
teins to glomerular structures appears to be partially related to
ionic interactions since high ionic strength buffers remove much
of the previously bound proteins. Also, prior incubation of
tissue sections with synthetic polyanions substantially blocks
subsequent glomerular binding of anionized proteins, further
suggesting an ionic interaction between anionic proteins and
glomerular structures. Since the above procedures did not fully
remove or prevent glomerular binding of anionic protein, inter-
actions other than charge may also be involved and need to be
considered; perhaps chemical interactions similar to concana-
valin A binding to GBM [26] or by hydrophobic interactions.
The observations in this study indicate that binding of highly
anionic macromolecules can partially be explained by ionic
interactions. These observations may have clinical relevance in
that the variety of negatively-charged plasma proteins men-
tioned above localize in glomerular and tubular basement
membranes, presumably by electrostatic interactions with fixed
positively-charged domains on proteins such as collagen [12].
Also, glomerular permeability to glycosylated proteins, which
are more anionic than their native counterparts, is facilitated in
normal and diseased subjects [13, 14]. A role for facilitated
permeability of anionic antibody in immune complex disease
has been suggested by the elution of anionic, in addition to
cationic, antibody from glomeruli of rats with Heymann nephri-
tis [27]. Moreover, such an anionic nature of antibody in
Heymann nephritis has been corroborated by Kerjaschki, Miet-
tinen and Farquhar [28]. Also DNA, a strong polyanion, has
been shown to have an affinity to collagen and the GBM in vitro
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globulin fraction (A and B). Electron dense deposits in the subendo-
thelium occur as amorphous material (A) and/or as multiple small
densities (B). The GBM is devoid of electron dense deposits in a
giomerular capillary wall of a rat injected with BSA followed by
anti-BSA (C).
[15]. These observations have broader clinical implications in
autoimmune disease such as systemic erythematosus where
circulating DNA, DNA antibodies, and DNA-anti-DNA com-
plexes occur concomitantly [22]. Thus, a role for negatively
charged antigens and/or antibodies in the pathogenesis of gb-
merulonephritis should not be overlooked, and further studies
in this area may provide useful insights into the pathogenesis of
immune complex disease.
Acknowledgments
This investigation was supported by research grants AM 17387 and
AM 30393 from the National Institutes of Health.
The authors acknowledge the technical assistance of Ron Reif and
Greg Potter, and the typing of the manuscript by Laura Gantt.
1. FARQUHAR MG, KAN WAR YS: Characterization of anionic sites in
the glomerular basement membranes of normal and nephrotic rats,
in Renal Pathophysiology, edited by LEAF A, GIEmscH G, BoLls
L, GORINI S, New York, Raven Press 1980, p. 57
2. VENKATACHALAM MA, RENNKE HG: The structural and molecular
basis of glomerular filtration. Circ Res 43:337—347, 1978
3. KANWAR YS, FARQUHAR MG: Anionic sites in the glomerular
basement membrane. In Vivo and In Vitro localization of the
laminae rarae by cationic probes. J Cell Biol 81:137—153, 1979
4. RENNKE HG, COTRAN RS, VENKATACHALAM MA: Role of molec-
ular charge in glomerular permeability: Tracer studies with cation-
ized ferritins. J Cell Biol 67:638—646, 1975
5. BARNES JL, LEVINE SP, VENKATACHALAM MA: Binding of platelet
factor four (PF 4) to glomerular polyanion. Kidney Int 25:759—765,
1984
6. BORDER WA, WARD HJ, Kamil ES, COHEN AH: Induction of
membranous nephropathy in rabbits by administration of an exog-
enous cationic antigen. Demonstration of a pathogenic role for
electrical charge. J Clin Invest 69:451—461, 1982
7. GALLO GR, CAULIN-GLASSER T, LAMM ME: Charge of circulating
immune complexes as a factor in glomerular basement membrane
localization in mice. J Clin Invest 67:1305—1313, 1981
8. OITE T, BATSFORD SR, MIHATSCH Mi, TAKAMIYA H, VOOT A:
Quantitative studies of in situ immune complex glomerubonephritis
in the rat induced by planted, cationized antigen. J Exp Med
155:460—474, 1982
9. BARNES JL, VENKATACHALAM MA: Enhancement of glomerular
immune complex deposition by a circulating polycation. J Exp Med
160:286—293, 1984
10. HOUSER MT, SCHEINMAN ii, BASGEN J, STEFFES MW, MICHAEL
AF: Preservation of mesangium and immunohistochemically de-
fined antigens in glomerular basement membrane isolated by deter-
gent extraction. J Clin Invest 69:1169-1175, 1982
Ii. TANAKA 5, HATA R, NAGAI Y: Two dimensional electrophoresis of
the chains of collagens and its application to the determination of
their isoelectric points. Collagen Ret Res 1:237—246, 1981
12. MELVIN T, YouNoiu K, MICHAEL AF: Selective binding of IgG4
and other negatively charged plasma proteins in normal and dia-
betic human kidneys. Am J Pathol 115:443—446, 1984
13. GHIGGERI GM, CANDIANO G, DELFINO G, QUEIROLO C: Electrical
charge of serum and urinary albumin in normal and diabetic
humans. Kidney Int 28:168—177, 1985
14. WILLIAMS SK, SIEGAL RK: Preferential transport of non-enzymat-
ically glucosylated ferritin across the kidney glomerulus. Kidney mt
28:146—152, 1985
15. Izul S, LAMBERT PH, MIESCHER PA: In vitro demonstration of a
particular affinity of glomerular basement membrane and collagen
for DNA. A possible basis for a local formation of DNA-anti-DNA
complexes in systemic lupus erythematosus. J Exp Med 114:428—
443, 1976
16. WEBER K, OsBoRN M: The reliability of molecular weight determi-
nations by dodecyl sulfate-polyacrylamide gel electrophoresis. J
Biol Chem 244:4406—4412, 1969
17. TUNG IS, KNIGHT CA: Relative importance of some factors
affecting the electrophoretic migration of proteins in sodium dode-
cyl sulfate-polyacrylamide gels. Anal Biochem 48:153—163, 1972
18. HABEEB AFSA: Quantitation of conformational changes on chem-
ical modification of proteins: Use of succinylated proteins as a
model. Arch Biochem Biophys 121:652—664, 1967
19. MCCLUSKEY RT, BENACERRAF B, MILLER F: Passive acute gb-
merubonephritis induced by antigen-antibody complexes solubilized
in hapten excess. Proc Soc Exp Biol Med 111:764-768, 1962
20. KABAT EA, MAYER MM: Experimental Immunochemistry. Spring-
field, IL, Charles C. Thomas, publisher, p. 22
21. LOWRY OH, ROSEBROUGH NI, FARR AL, RANDALL RJ: Protein
measurement with the foline phenol reagent. J Biol Chem 193:265—
277, 1951
a'Y. SL5
A
;.tw
Barnes et al: Negative charge and immune complex formation 163
22. WILsoN CB, DIXON FJ: The renal response to immunological
injury, in The Kidney, edited by BRENNER BM, RECTOR FC.
Philadelphia, PA, W.B. Saunders Co., p. 800
23. MICHAEL AF, KEANE WF, RAIJ L, VERNIER RL, MAUER SM: The
glomerular mesangium. Kidney mt 17:141—154, 1980
24. MICHAEL AF, Fisn AJ, GooD RA: Glomerular localization and
transport of aggregated proteins in mice. Lab invest 17:14—29, 1967
25. LEE S, VERNIER RL: Immunoelectron microscopy of the glomeru-
lar mesangial uptake and transport of aggregated human albumin in
the mouse. Lab invest 42:44—58, 1980
26. GOLBUS SM, WILsoN CB: Experimental glomerulonephritis in-
duced by in situ formation of immune complexes in glomerular
capillary wall. Kidney mt 16:148—157, 1979
27. MADAIO MP, ADLER S, GROGGEL GC, COUSER WG, SALANT DJ:
Charge selective properties of the glomerular capillary wall influ-
ence antibody binding in rat membranous nephropathy. Clin Im-
munol immunopathol 39:13 1—138, 1986
28. KERJASCHKI D, MIETTINEN A, FARQUHAR MG: Initial events in the
formation of immune deposits in passive Heymann nephritis.
gp330-anti-gp330 immune complexes form in epithelial Coated pits
and rapidly become attached to glomerular basement membranes. J
Exp Med 166:109—128, 1987
